AAV-ie enables safe and efficient gene transfer to inner ear cells

Nat Commun. 2019 Aug 19;10(1):3733. doi: 10.1038/s41467-019-11687-8.

Abstract

Hearing loss is the most common sensory disorder. While gene therapy has emerged as a promising treatment of inherited diseases like hearing loss, it is dependent on the identification of gene delivery vectors. Adeno-associated virus (AAV) vector-mediated gene therapy has been approved in the US for treating a rare inherited eye disease but no safe and efficient vectors have been identified that can target the diverse types of inner ear cells. Here, we identify an AAV variant, AAV-inner ear (AAV-ie), for gene delivery in mouse inner ear. Our results show that AAV-ie transduces the cochlear supporting cells (SCs) with high efficiency, representing a vast improvement over conventional AAV serotypes. Furthermore, after AAV-ie-mediated transfer of the Atoh1 gene, we find that many SCs trans-differentiated into new HCs. Our results suggest that AAV-ie is a useful tool for the cochlear gene therapy and for investigating the mechanism of HC regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Transcription Factors / genetics*
  • Cells, Cultured
  • Dependovirus / genetics*
  • Female
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Genetic Vectors / genetics
  • Hair Cells, Auditory, Inner / cytology*
  • Hearing Loss / genetics*
  • Hearing Loss / therapy*
  • Male
  • Mice
  • Mice, Inbred C57BL

Substances

  • Atoh1 protein, mouse
  • Basic Helix-Loop-Helix Transcription Factors